Fingerprint
Dive into the research topics of 'Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab
David Lim, Rhiannon Bandiera, Elizabeth Handsley
Research output: Contribution to journal › Letter › peer-review
2
Citations
(Scopus)